Novel instrument to measure water uptake, dissolution and hygroscopic growth of an individual levitated aerosol particle in an environment identical to the lung (relative humidity >99.5%)

Allen Haddrell,David Lewis,Tanya Church,Jonathan Reid

DOI: https://doi.org/10.1080/02786826.2024.2330482

2024-04-05

Aerosol Science and Technology

Abstract:Dry powder inhalers (DPIs) are commonly used devices for delivering inhalable pharmaceuticals. The overall efficacy of any inhalable pharmaceutical is a function of total and regional dose, and the bioavailability of the active pharmaceutical ingredient upon deposition in the lung. Thus, a detailed understanding of the dissolution dynamics of particles from a DPI from the point of generation through to deposition in the lung may shed additional insights into the interpretation of the pharmacokinetic effects, resulting in the design of improved formulations. We present the design and benchmarking of a novel technology that directly measures the dissolution dynamics of dry aerosol particles in situ , where the relative humidity and temperature are directly comparable to the highly humid conditions within the lungs. The rate of water uptake (mass) as well as changes in the physical structure of the particle are directly measured using a combination of electrodynamics and laser light scatter. This technique offers unique insights into the dissolution dynamics of DPI starting formulations.

environmental sciences,meteorology & atmospheric sciences,engineering, chemical, mechanical

What problem does this paper attempt to address?

This paper presents a new instrument design for measuring the hygroscopicity, dissolution, and humidification growth of individual suspended aerosol particles in an environment similar to the lungs (relative humidity exceeding 99.5%). This research mainly focuses on the drug delivery issues in dry powder inhalers (DPIs) as the drug efficacy of DPIs depends on the dissolution dynamics of drug particles during inhalation. Traditional dissolution rate measurement methods cannot simulate the actual environment of particles in the human lungs in the aerosol phase. The new device combines electrodynamics and laser scattering techniques to directly measure the mass changes and physical structural changes of particles, thus gaining insights into the dissolution dynamics of DPI starting formulations. This helps optimize the design of inhaled drugs and improve their bioavailability and efficacy.